Article

Intravascular detection of inflamed atherosclerotic plaques using a fluorescent photosensitizer targeted to the scavenger receptor

Department of Medicine (Cardiac Unit), Massachusetts General Hospital, Boston, MA 02114, USA.
Photochemical and Photobiological Sciences (Impact Factor: 2.94). 01/2008; 7(1):33-9. DOI: 10.1039/b710746c
Source: PubMed

ABSTRACT Inflammation plays an important role in the pathophysiology of atherosclerotic disease. We have previously shown that the targeted photosensitizer chlorin (e(6)) conjugated with maleylated albumin (MA-ce6) is taken up by macrophages via the scavenger receptor with high selectivity. In a rabbit model of inflamed plaque in New Zealand white rabbits via balloon injury of the aorto-iliac arteries and high cholesterol diet we showed that the targeted conjugate showed specificity towards plaques compared to free ce6. We now show that an intravascular fiber-based spectrofluorimeter advanced along the -iliac vessel through blood detects 24-fold higher fluorescence in atherosclerotic vessels compared to control rabbits (p < 0.001 ANOVA). Within the same animals, signal derived from the injured iliac artery was 16-fold higher than the contralateral uninjured iliac (p < 0.001). Arteries were removed and selective accumulation of MA-ce6 in plaques was confirmed using: (1) surface spectrofluorimetry, (2) fluorescence extraction of ce6 from aortic segments, and (3) confocal microscopy. Immunohistochemical analysis of the specimens showed a significant correlation between MA-ce6 uptake and RAM-11 macrophage staining (R = 0.83, p < 0.001) and an inverse correlation between MA-ce6 uptake and smooth muscle cell staining (R = -0.74, p < 0.001). MA-ce6 may function as a molecular imaging agent to detect and/or photodynamically treat inflamed plaques.

0 Followers
 · 
100 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Maleylated bovine serum albumin is a known ligand for targeting macrophages and has potential as a carrier for molecular imaging purposes. We present a novel synthesis of glycolaldehyde-conjugated human serum albumin (GA-HSA) and maleylated human serum albumin (Mal-HSA). Seventeen modifications of fluorescently tagged GA-HSA and Mal-HSA molecules with different degrees of conjugation were prepared. The comparative uptake studies, using 12 of these modifications, were done in vitro on mouse monocytes/macrophages (RAW264.7), and evaluated qualitatively by confocal microscopy and quantitatively by flow cytometry. The GA modifications are taken up by the macrophages approximately 40% better than the maleyl modifications at low concentrations (≤3 μm), while at higher concentrations it appears that the maleyl modifications are taken up around 25–44% better than the GA-modified HSA. However, high uptake at low concentrations will be beneficial for in vivo localizing inflammation in areas with low penetration of the probe as in an atherosclerotic plaque. Further, another advantage of GA-HSA is that GA competes less than the maleyl group for the free reactive amine sites that are to be used for conjugation of metal chelating ligands (e.g. tetraazacyclododecanetetraacetic acid and triazacyclononanetriacetic acid). Metal ions such as Gd3+ and Mn2+ can be chelated for positive Magnetic Resonance (MR) contrast and positron emitting ions such as 64Cu2+ and 68Ga3+ for Positron Emission Tomography (PET) imaging. These are important properties, especially, when considering the MR contrast possibilities owing to the low sensitivity of the technique, and would motivate the use of GA-HSA before Mal-HSA. © 2014 The Authors. Contrast Media & Molecular Imaging published by John Wiley & Sons, Ltd.
    Contrast Media & Molecular Imaging 04/2014; 10(1). DOI:10.1002/cmmi.1598 · 3.33 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ultrasound imaging, having the advantages of low-cost and non-invasiveness over MRI and X-ray CT, was reported by several studies as an adequate complement to fluorescence molecular tomography with the perspective of improving localization and quantification of fluorescent molecular targets in vivo. Based on the previous work, an improved dual-modality Fluorescence-Ultrasound imaging system was developed and then validated in imaging study with preclinical tumor model. Ultrasound imaging and a profilometer were used to obtain the anatomical prior information and 3D surface, separately, to precisely extract the tissue boundary on both sides of sample in order to achieve improved fluorescence reconstruction. Furthermore, a pattern-based fluorescence reconstruction on the detection side was incorporated to enable dimensional reduction of the dataset while keeping the useful information for reconstruction. Due to its putative role in the current imaging geometry and the chosen reconstruction technique, we developed an attenuation compensated Born-normalization method to reduce the attenuation effects and cancel off experimental factors when collecting quantitative fluorescence datasets over large area. Results of both simulation and phantom study demonstrated that fluorescent targets could be recovered accurately and quantitatively using this reconstruction mechanism. Finally, in vivo experiment confirms that the imaging system associated with the proposed image reconstruction approach was able to extract both functional and anatomical information, thereby improving quantification and localization of molecular targets.
    Review of Scientific Instruments 05/2014; 85(5):053703-053703-12. DOI:10.1063/1.4875256 · 1.58 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Direct assessment of the vascular wall provides the capability to monitor atherosclerosis progression and assess the response to pharmacotherapy as a surrogate to clinical outcomes. Carotid intima-media thickness (IMT) using high-frequency ultrasound (10 MHz) accurately measures arterial wall thickness, with the recommendation that the far wall of the common carotid artery is the optimal site for serial assessment. A 15–18% increase in relative risk for myocardial infarction and stroke is observed for each 0.10 mm increase in carotid IMT. Inter-test reproducibility is high, but the application to individual patients is limited by generally slow progression of IMT. Coronary artery calcium correlates to overall atherosclerosis burden and independently predicts incident cardiovascular events up to tenfold over standard risk factors. Progression of coronary calcium is rapid, and a rate ≥15% per year clinically identifies individuals with increased cardiovascular risk. A complicated relationship exists between cardiovascular risk factor modification and coronary calcium progression, such that its use in pharmacotherapy evaluation is limited. Contrast enhanced CT angiography provides the ability to image both calcified and non-calcified coronary atherosclerosis, but requires careful attention to image quality. Nuclear imaging of the vascular wall, with positron emission tomography, targets inflammation within the vascular wall of larger vessels. Pharmacotherapies with anti-inflammatory properties may be studied with FDG-PET, but these findings have not yet been related to cardiovascular outcomes.

Full-text (2 Sources)

Download
17 Downloads
Available from
Jun 5, 2014